Medindia
Medindia LOGIN REGISTER
Advertisement

Boehringer Ingelheim and MD Anderson Form Unique Virtual Research and Development Center to Rapidly Advance New Cancer Therapies

Monday, August 12, 2019 General News
Advertisement
-- New potential gastrointestinal and lung cancer therapies from Boehringer Ingelheim's innovative oncology pipeline will be combined with the patient-driven drug-development capabilities at MD Anderson

Boehringer Ingelheim

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close